FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3157178945> ?p ?o ?g. }

• W3157178945 endingPage "140" @default.
• W3157178945 startingPage "130" @default.
• W3157178945 abstract "Participation in clinical trials is essential to bringing novel and innovative cancer treatments to the bedside but trials that specifically enroll Veterans are relatively few. Given the inherent differences between Veterans and the general United States population, we sought to investigate awareness of and attitudes toward clinical trials among Veterans diagnosed with cancer at a large, urban Veterans Administration Medical Center in Bronx, New York. The survey was administered in 2018-2019. Questions assessed sociodemographic characteristics, health literacy, and general attitudes about clinical trials. Based on key informant interviews, we also inquired about military-specific attitudes. Univariable analyses were conducted to evaluate differences in attitudes by age (<65 v ≥65 years) and race/ethnicity (non-Hispanic black v other). Of 115 Veterans approached, 67 (58.3%) completed the survey. Approximately 95% of participants were male, 59.7% were ≥65 years old, and 41.8% were non-Hispanic black. Only 58.2% reported knowing what a clinical trial is but 78.5% of Veterans stated that they trust doctors who do medical research and 87.5% reported they would strongly consider joining a trial if their VA primary care physician recommended it. Many stated that they would be part of a clinical trial if it would help fellow Veterans in the future (93.8%) and would help scientists learn how to treat other Veterans with the same disease (93.8%). Among non-Hispanic black participants, 62.5% agreed that the government has a history of using Veterans in experiments without their knowledge compared to 34.2% of Veterans of other race/ethnicity (P = 0.03). Clearly Veterans in our study were amenable to joining clinical trials. While many are aware of past misconduct in the treatment of military personnel in research, overall attitudes toward clinical trials were favorable and were especially positive when the possibility of improving cancer care for fellow Veterans was considered. In approaching Veterans regarding participation in a clinical trial we recommend education aligned with the literacy level of the Veteran, involvement of the VA primary care provider in clinical trial decisions, and awareness of a Veteran's altruism to help others." @default.
• W3157178945 created "2021-05-10" @default.
• W3157178945 creator A5013592290 @default.
• W3157178945 creator A5039574165 @default.
• W3157178945 creator A5040839606 @default.
• W3157178945 creator A5048876219 @default.
• W3157178945 creator A5059499067 @default.
• W3157178945 creator A5077305663 @default.
• W3157178945 date "2021-04-01" @default.
• W3157178945 modified "2023-09-30" @default.
• W3157178945 title "Positive attitudes toward clinical trials among military veterans leaves unanswered questions about poor trial accrual" @default.
• W3157178945 cites W165608748 @default.
• W3157178945 cites W1912092396 @default.
• W3157178945 cites W1939886924 @default.
• W3157178945 cites W1994843850 @default.
• W3157178945 cites W2011289170 @default.
• W3157178945 cites W2017256771 @default.
• W3157178945 cites W2064370814 @default.
• W3157178945 cites W2073944740 @default.
• W3157178945 cites W2075765029 @default.
• W3157178945 cites W2109575571 @default.
• W3157178945 cites W2109659496 @default.
• W3157178945 cites W2112276490 @default.
• W3157178945 cites W2126800506 @default.
• W3157178945 cites W2128251606 @default.
• W3157178945 cites W2133689391 @default.
• W3157178945 cites W2165508079 @default.
• W3157178945 cites W2168315952 @default.
• W3157178945 cites W2169767348 @default.
• W3157178945 cites W2226419169 @default.
• W3157178945 cites W2303577864 @default.
• W3157178945 cites W2346544020 @default.
• W3157178945 cites W2594781738 @default.
• W3157178945 cites W2601447203 @default.
• W3157178945 cites W2613736770 @default.
• W3157178945 cites W2767157066 @default.
• W3157178945 cites W2889242229 @default.
• W3157178945 cites W2908722991 @default.
• W3157178945 cites W2909769604 @default.
• W3157178945 cites W2915663023 @default.
• W3157178945 cites W2940173580 @default.
• W3157178945 cites W2982103077 @default.
• W3157178945 cites W2992103041 @default.
• W3157178945 cites W3003309896 @default.
• W3157178945 cites W437024349 @default.
• W3157178945 doi "https://doi.org/10.1053/j.seminoncol.2021.04.001" @default.
• W3157178945 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8530825" @default.
• W3157178945 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34088517" @default.
• W3157178945 hasPublicationYear "2021" @default.
• W3157178945 type Work @default.
• W3157178945 sameAs 3157178945 @default.
• W3157178945 citedByCount "0" @default.
• W3157178945 crossrefType "journal-article" @default.
• W3157178945 hasAuthorship W3157178945A5013592290 @default.
• W3157178945 hasAuthorship W3157178945A5039574165 @default.
• W3157178945 hasAuthorship W3157178945A5040839606 @default.
• W3157178945 hasAuthorship W3157178945A5048876219 @default.
• W3157178945 hasAuthorship W3157178945A5059499067 @default.
• W3157178945 hasAuthorship W3157178945A5077305663 @default.
• W3157178945 hasBestOaLocation W31571789452 @default.
• W3157178945 hasConcept C121955636 @default.
• W3157178945 hasConcept C126322002 @default.
• W3157178945 hasConcept C137403100 @default.
• W3157178945 hasConcept C144024400 @default.
• W3157178945 hasConcept C144133560 @default.
• W3157178945 hasConcept C160735492 @default.
• W3157178945 hasConcept C162324750 @default.
• W3157178945 hasConcept C19165224 @default.
• W3157178945 hasConcept C2775969662 @default.
• W3157178945 hasConcept C2778843546 @default.
• W3157178945 hasConcept C2781426361 @default.
• W3157178945 hasConcept C2908647359 @default.
• W3157178945 hasConcept C4577558 @default.
• W3157178945 hasConcept C50522688 @default.
• W3157178945 hasConcept C512399662 @default.
• W3157178945 hasConcept C535046627 @default.
• W3157178945 hasConcept C71924100 @default.
• W3157178945 hasConcept C74909509 @default.
• W3157178945 hasConcept C99454951 @default.
• W3157178945 hasConceptScore W3157178945C121955636 @default.
• W3157178945 hasConceptScore W3157178945C126322002 @default.
• W3157178945 hasConceptScore W3157178945C137403100 @default.
• W3157178945 hasConceptScore W3157178945C144024400 @default.
• W3157178945 hasConceptScore W3157178945C144133560 @default.
• W3157178945 hasConceptScore W3157178945C160735492 @default.
• W3157178945 hasConceptScore W3157178945C162324750 @default.
• W3157178945 hasConceptScore W3157178945C19165224 @default.
• W3157178945 hasConceptScore W3157178945C2775969662 @default.
• W3157178945 hasConceptScore W3157178945C2778843546 @default.
• W3157178945 hasConceptScore W3157178945C2781426361 @default.
• W3157178945 hasConceptScore W3157178945C2908647359 @default.
• W3157178945 hasConceptScore W3157178945C4577558 @default.
• W3157178945 hasConceptScore W3157178945C50522688 @default.
• W3157178945 hasConceptScore W3157178945C512399662 @default.
• W3157178945 hasConceptScore W3157178945C535046627 @default.
• W3157178945 hasConceptScore W3157178945C71924100 @default.
• W3157178945 hasConceptScore W3157178945C74909509 @default.
• W3157178945 hasConceptScore W3157178945C99454951 @default.

• next